Addition | B6 anti-BALB/c, ng/ml (SI) | TLR-2-/- anti-BALB/c, ng/ml (SI) |
---|---|---|
Anti-haIgG | 0.2 | 0.3 |
   + Lip-OspA | 2.3a (11.5) | 0.2 (<1) |
   + MDP-OspA | 0.3 (1.5) | 0.2 (<1) |
   + rec. IL-2 | 0.5 (2.5) | 0.4 (1.3) |
   + LPS | 0.2 (1.0) | 0.4 (1.3) |
0.03 ng per well anti-CD3 | 0.2 | 0.3 |
   + anti-CD3 + Lip-OspA | 5.4a (27) | 0.2 (<1) |
   + anti-CD3 + MDP-OspA | 0.2 (1.0) | 0.3 (1.0) |
   + anti-CD3 + rec. IL-2 | 0.8a (4.0) | 0.6 (2.0) |
   + anti-CD3 + LPS | 0.3 (1.5) | 0.1 (<1) |
0.3 ng per well anti-CD3 | 4.9 | 7.2 |
   + anti-CD3 + Lip-OspA | 29.1a (5.9) | 6.8 (<1) |
   + anti-CD3 + MDP-OspA | 6.0 (1.2) | 9.5 (1.3) |
   + anti-CD3 + rec. IL-2 | 10.9a (2.2) | 10.2 (1.4) |
   + anti-CD3 + LPS | 2.7 (<1) | 7.2 (1.0) |